ChatGPT and Artificial Intelligence, a Warning Signal for the Editorial Process of Medical Journals

Authors

Abstract

ChatGPT e inteligencia artificial, señal de alerta para el proceso editorial de revistas médicas

Downloads

Download data is not yet available.

Author Biography

Junior Vega Jiménez, Universidad de Ciencias Médicas de Matanzas, Hospital Militar Docente Dr. Mario Muñoz Monroy.

Joven Asociado a la Academia de Ciencias de Cuba

References

Stokel-Walker C. AI bot ChatGPT writes smart essays-should professors worry? Nature. 2022. DOI: https://doi.org/10.1038/d41586-022-04397-7 PMID: 36494443.

Else H. Abstracts written by ChatGPT fool scientists. Nature. 2023 [acceso 01/03/2023];613(7944):423. Disponible en: https://www.nature.com/articles/d41586-023-00056-7

King MR. A Conversation on Artificial Intelligence, Chatbots, and Plagiarism in Higher Education. Cellular and molecular bioengineering. 2023 [acceso 02/04/2023];16(1):1-2. Disponible en: https://link.springer.com/article/10.1007/s12195-022-00754-8

D'Amico RS, White TG, Shah HA, Langer DJ. I Asked a ChatGPT to Write an Editorial About How We Can Incorporate Chatbots Into Neurosurgical Research and Patient Care. Neurosurgery. 2023;92(4):663-4. DOI: https://doi.org/10.1227/neu.0000000000002414

Tools such as ChatGPT threaten transparent science; here are our ground rules for their use. Nature. 2023;613(7945):612. DOI: https://doi.org/doi:10.1038/d41586-023-00191-1

Kung TH, Cheatham M, Medenilla A, Sillos C, De Leon L, Elepaño C, et al. Performance of ChatGPT on USMLE: Potential for AI-Assisted Medical Education Using Large Language Models. medRxiv. 2022 [acceso 01/04/2023];1-25. Disponible en: https://www.medrxiv.org/content/10.1101/2022.12.19.22283643v2

Blanco-González A, Cabezon A, Seco-González A, Conde-Torres D, Antelo-Riveiro P, Piñeiro A, et al. The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies. Pharmaceuticals. 2023 [acceso 02/01/2023];16(6),891. Disponible en: https://www.mdpi.com/1424-8247/16/6/891

Zhavoronkov A. Rapamycin in the context of Pascal's Wager: generative pre-trained transformer perspective. Oncoscience. 2022 [acceso 21/03 /2023];9:82-4. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796173/

Gao CA, Howard FM, Markov NS, Dyer EC, Ramesh S, Luo Y, et al. Comparing scientific abstracts generated by ChatGPT to original abstracts using an artificial intelligence output detector, plagiarism detector, and blinded human reviewers. bioRxiv. 2022;1-18. DOI: https://doi.org/10.1101/2022.12.23.521610

Hosseini M, Rasmussen LM, Resnik DB. Using AI to write scholarly publications. Accountability in research. 2023 [acceso 03/04 /2023]:1-9. DOI: https://doi.org/10.1080/08989621.2023.2168535

Stokel-Walker C. ChatGPT listed as author on research papers: many scientists disapprove. Nature. 2023 [acceso 10/04 /2023];613(7945):620-1. Disponible en: https://pubmed.ncbi.nlm.nih.gov/36653617/

Yeo-Teh NSL, Tang BL. Letter to Editor: NLP systems such as ChatGPT cannot be listed as an author because these cannot fulfill widely adopted authorship criteria. Accountability in research. 2023 [acceso 01/04/2023];1-3. Disponible en: https://pubmed.ncbi.nlm.nih.gov/36748354/

Downloads

Published

2023-09-18

How to Cite

1.
Vega Jiménez J, Lorente Leyva LL, Medina Leon A. ChatGPT and Artificial Intelligence, a Warning Signal for the Editorial Process of Medical Journals. Rev. cuba. inf. cienc. salud [Internet]. 2023 Sep. 18 [cited 2025 Mar. 15];34. Available from: https://acimed.sld.cu/index.php/acimed/article/view/2515

Issue

Vol. 34 (2023): Publicación continua

Section

Cartas al Editor

License

Aquellos autores que tengan publicaciones con esta revista, aceptan los términos siguientes:

  1. Los autores conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0) que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
  2. Los autores podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un repositorio institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
  3. Se permite y recomienda a los autores difundir su obra a través de Internet (p. ej.: en repositorios institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto). En ese caso, solicitamos que en la cabecera del manuscrito se indique:"Esta es una versión preprint enviada a la Revista Cubana de Información en Ciencias de la Salud http://rcics.sld.cu/"

ENGLISH VERSION

AUTHORS WITH PUBLICATIONS IN THIS JOURNAL ACCEPT THE FOLLOWING TERMS:

  • Authors will retain their copyright and will grant the Journal the right of first publication of their work, which will also be subject to a Creative Commons  License Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) allowing third parties to share the work as long as the author's name and data about initial publication in this Journal are stated.
  • Authors may adopt other license agreements for non-exclusive distribution of the version of the work published (e.g. deposit it in an institutional repository or publish it in a monographic volume), as long as initial publication in this Journal is indicated.
  • It is permitted and recommended for authors to disseminate their work on the Internet (e.g. in institutional repositories or their web page) before and during the submission process, which may result in interesting exchanges and increase the number of citations of the published work) (see The effect of open access).